サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1575016

梅毒免疫測定診断市場：検査タイプ別、検体タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測

Syphilis Immunoassay Diagnostic Market, By Test Type, By Sample Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
梅毒免疫測定診断市場：検査タイプ別、検体タイプ別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

梅毒免疫測定診断市場規模は2023年に291億932万米ドルとなり、2024年から2032年にかけてCAGR 7.60%で拡大

梅毒免疫測定診断市場-市場力学

正確かつ迅速な診断検査に対する需要の急増が梅毒免疫測定診断市場の成長を促進

梅毒の正確かつ迅速な診断検査に対する緊急性の高まりは、免疫測定診断薬市場に大きな影響を与えています。世界保健機関（WHO）の報告によると、世界の梅毒罹患率は特にハイリスク集団の間で上昇しており、効果的なスクリーニングの必要性が浮き彫りになっています。ポイント・オブ・ケア検査のような革新的な検査法では、30分以内に結果が得られるため、患者の管理と治療成績が向上します。米国では、梅毒患者が2014年から2018年にかけて75％近く増加したことを疾病対策予防センターが取り上げており、ヘルスケアプロバイダーは迅速な検査ソリューションを優先するよう求められています。性感染症全体の増加により、信頼性の高い診断検査に対する需要がさらに高まり、主要ヘルスケア企業による研究開発への投資が増加しています。この動向は、梅毒の蔓延を抑制し、公衆衛生への対応を改善する上で、迅速な診断能力が重要な役割を果たすことを強調しています。

梅毒免疫測定診断市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約7.60%のCAGRで毎年成長すると予測されています。

検査タイプ別では、ポイントオブケア（POC）検査が2023年に最大市場シェアを示すと予測されます。

検体タイプ別では、血液が2023年の主要タイプでした。

地域別では、北米が2023年の主要収益源でした。

梅毒免疫測定診断市場-セグメンテーション分析：

梅毒免疫測定診断の世界市場は、検査タイプ、検体タイプ、エンドユーザー、地域に基づいてセグメント化されます。

市場は検査タイプに基づいて4つのカテゴリーに分けられる：トレポネーマル検査、非トレポネーマル検査、ポイントオブケア（POC）検査、自動免疫測定法。ポイント・オブ・ケア（POC）検査は、その迅速な結果と使いやすさから主流になると予測されます。その後に続くのは、トレポネーマル検査、非トレポネーマル検査、自動免疫測定法で、それぞれ診断において独自の利点を提供しています。

市場は検体タイプによって3つのカテゴリーに分けられる：血液、血清、血漿です。血液サンプルは、広く入手可能で採取が容易であることから、市場をリードすると予想されます。次いで、検査における安定性から血清検体、血漿検体も一般的に診断に利用されています。

梅毒免疫測定診断市場-地理的洞察

梅毒免疫測定診断市場は地理的変動が大きく、中でも北米はヘルスケアのインフラが発達しており、性感染症の有病率も高いため、市場をリードしています。米国疾病予防管理センター（Centers for Disease Control and Prevention）は梅毒患者の急増を指摘し、スクリーニングと検査能力を強化するイニシアチブを促しました。欧州では、英国やドイツのような国が革新的な診断技術に投資しており、欧州疾病予防管理センターは早期発見・早期治療の重要性を強調しています。アジア太平洋は、意識の高まりとヘルスケアの改善によって急速な成長を遂げています。例えば、インドではハイリスク集団の梅毒スクリーニングに取り組む国家プログラムが実施されています。ラテンアメリカも躍進しており、ブラジルは迅速診断検査を公衆衛生戦略に組み込む取り組みを報告しています。一方、中東とアフリカは、資源の制約など独自の課題に直面しているが、性感染症の負担軽減を目指す国際保健機関に後押しされ、より効果的な検査法を採用し始めています。

梅毒免疫測定診断市場-競合情勢：

梅毒免疫測定診断市場の競合情勢は、様々な地域で大きな動きを見せています。北米はAbbott LaboratoriesやRocheのような主要プレーヤーが梅毒検査の精度とスピードを高めるために高度な免疫測定技術に投資しています。American Sexual Health Association（米国性病協会）は、梅毒の発生を抑制するには迅速検査法が重要であると報告しています。欧州では、シーメンス・ヘルスイニアーズやバイオメリューなどの企業が、STI検査と治療プロトコルの改善に対する欧州連合のイニシアティブに支えられ、技術革新を推進しています。アジア太平洋地域では、FujirebioやTecanといった企業が市場での存在感を高めており、日本とオーストラリアは包括的なスクリーニングプログラムを重視しています。ラテンアメリカも競争の場となりつつあり、世界保健機関（WHO）が梅毒蔓延の減少に重点を置いていることを反映して、現地企業は診断検査へのアクセスを改善するために国際企業と提携しています。中東・アフリカでは、性の健康に対する認識を高めるための非政府組織のイニシアティブに支えられ、手頃な価格の検査キットのイントロダクションよって市場が発展しつつあります。

目次

第1章 梅毒免疫測定診断市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 梅毒免疫測定診断の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 梅毒免疫測定診断産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 梅毒免疫測定診断市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 梅毒免疫測定診断市場情勢

  • 梅毒免疫測定診断市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 梅毒免疫測定診断市場- 検査タイプ別

  • 概要
    • 検査タイプ別セグメントシェア分析
    • トレポネーマ検査
    • 非トレポネーマ検査
    • ポイントオブケア（POC）テスト
    • 自動免疫測定

第8章 梅毒免疫測定診断市場- 検体タイプ別

  • 概要
    • 検体タイプ別セグメントシェア分析
    • 血液
    • 血清
    • 血漿

第9章 梅毒免疫測定診断市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 診断検査室
    • 血液バンク
    • 地域のクリニック

第10章 梅毒免疫測定診断市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 梅毒免疫測定診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories, Inc.
    • Cardinal Health, Inc.
    • Cepheid Inc.（Danaher）
    • Chembio Diagnostics, Inc.
    • DiaSorin SpA
    • F. Hoffmann-La Roche AG
    • Hologic, Inc.
    • OraSure Technologies, Inc.
    • Qiagen NV
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech plc
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV4011

REPORT HIGHLIGHT

The Syphilis Immunoassay Diagnostic Market size was valued at USD 29,109.32 million in 2023, expanding at a CAGR of 7.60% from 2024 to 2032.

The Syphilis Immunoassay Diagnostic Market encompasses various testing methods used to detect syphilis infections, which remain a significant public health concern globally. With rising rates of syphilis, particularly among certain demographics, the demand for accurate and rapid diagnostic tests has surged. Increased awareness and education regarding sexually transmitted infections (STIs) have contributed to higher testing rates. Moreover, government initiatives aimed at reducing STI prevalence have bolstered market growth. However, challenges such as the availability of alternative testing methods and the stigma surrounding STIs may restrain market expansion. Opportunities lie in the development of novel immunoassay technologies and point-of-care testing solutions, which can enhance accessibility and facilitate timely treatment. For instance, the CDC reported a 20% increase in reported syphilis cases in recent years, highlighting the urgent need for improved diagnostic tools and public health interventions.

Syphilis Immunoassay Diagnostic Market- Market Dynamics

Surge in Demand for Accurate and Rapid Diagnostic Tests Propels Growth in the Syphilis Immunoassay Diagnostic Market

The growing urgency for accurate and rapid diagnostic tests for syphilis has significantly influenced the market for immunoassay diagnostics. The World Health Organization reported that global syphilis rates have risen, particularly among high-risk populations, underscoring the need for effective screening. Innovative testing methods, such as point-of-care tests, provide results in under 30 minutes, enhancing patient management and treatment outcomes. In the U.S., the Centers for Disease Control and Prevention highlighted that syphilis cases increased by nearly 75% from 2014 to 2018, prompting healthcare providers to prioritize swift testing solutions. The rise in sexually transmitted infections overall has further driven the demand for reliable diagnostic tests, leading to increased investments in research and development by major healthcare companies. This trend emphasizes the critical role of rapid diagnostic capabilities in controlling the spread of syphilis and improving public health responses.

Syphilis Immunoassay Diagnostic Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.60% over the forecast period (2024-2032)

Based on Test Type segmentation, Point-of-care (POC) Tests were predicted to show maximum market share in the year 2023

Based on Sample Type segmentation, Blood was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Syphilis Immunoassay Diagnostic Market- Segmentation Analysis:

The Global Syphilis Immunoassay Diagnostic Market is segmented on the basis of Test Type, Sample Type, End-User, and Region.

The market is divided into four categories based on Test Type: Treponemal Tests, Non-Treponemal Tests, Point-of-Care (POC) Tests, and Automated Immunoassays. Point-of-care (POC) Tests are predicted to dominate due to their rapid results and ease of use. Following closely are Treponemal Tests, Non-Treponemal Tests, and Automated Immunoassays, each offering unique benefits in diagnostics.

The market is divided into three categories based on Sample Type: Blood, Serum, and Plasma. Blood samples are expected to lead due to their widespread availability and ease of collection. Following are Serum samples, favored for their stability in testing, and Plasma samples, which are also commonly utilized in diagnostics.

Syphilis Immunoassay Diagnostic Market- Geographical Insights

The Syphilis Immunoassay Diagnostic Market exhibits significant geographical variation, with North America leading due to its advanced healthcare infrastructure and high prevalence of sexually transmitted infections. The Centers for Disease Control and Prevention noted a surge in syphilis cases, prompting initiatives to enhance screening and testing capabilities. In Europe, countries like the UK and Germany are investing in innovative diagnostic technologies, with the European Centre for Disease Prevention and Control emphasizing the importance of early detection and treatment. Asia-Pacific is witnessing rapid growth, driven by increasing awareness and healthcare improvements; for instance, India has implemented national programs to address syphilis screening among high-risk populations. Latin America is also making strides, with Brazil reporting efforts to integrate rapid diagnostic tests into public health strategies. Meanwhile, the Middle East and Africa face unique challenges, including resource constraints, but are beginning to adopt more effective testing methods, spurred by international health organizations aiming to reduce the burden of sexually transmitted infections.

Syphilis Immunoassay Diagnostic Market- Competitive Landscape:

The competitive landscape of the Syphilis Immunoassay Diagnostic Market showcases significant activity across various regions. North America leads with key players like Abbott Laboratories and Roche, which are investing in advanced immunoassay technologies to enhance accuracy and speed in syphilis testing. The American Sexual Health Association has reported that rapid testing methods are crucial in controlling syphilis outbreaks. In Europe, companies such as Siemens Healthineers and BioMerieux are driving innovation, supported by the European Union's initiatives to improve STI testing and treatment protocols. In the Asia-Pacific region, firms like Fujirebio and Tecan are expanding their market presence, with Japan and Australia emphasizing comprehensive screening programs. Latin America is also becoming a competitive arena, where local companies are partnering with international firms to improve access to diagnostic tests, reflecting the World Health Organization's focus on reducing syphilis prevalence. In the Middle East and Africa, the market is evolving with the introduction of affordable testing kits, supported by initiatives from non-governmental organizations to bolster sexual health awareness.

Recent Developments:

In August 2024, NowDiagnostics' First to Know(R) syphilis test received FDA de novo marketing authorization for over-the-counter use. This immunoassay diagnostic allows individuals to test for syphilis at home, enhancing accessibility and early detection of the infection.

In November 2021, MedAccess, CHAI, and SD Biosensor announced a partnership to provide a dual rapid test for syphilis and HIV for under $1 in over 100 low- and middle-income countries. This test enables quick diagnosis, improving maternal health and reducing stillbirths linked to syphilis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson, and Company
  • bioMerieux S.A.
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • Cepheid Inc. (Danaher)
  • Chembio Diagnostics, Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • OraSure Technologies, Inc.
  • Qiagen N.V.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc
  • Others

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Treponemal Tests
  • Non-Treponemal Tests
  • Point-of-Care (POC) Tests
  • Automated Immunoassays

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Blood
  • Serum
  • Plasma

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Diagnostic Laboratories
  • Blood Banks
  • Community Clinics

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Syphilis Immunoassay Diagnostic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Syphilis Immunoassay Diagnostic Market Snippet by Test Type
    • 2.1.2. Syphilis Immunoassay Diagnostic Market Snippet by Sample Type
    • 2.1.3. Syphilis Immunoassay Diagnostic Market Snippet by End-User
    • 2.1.4. Syphilis Immunoassay Diagnostic Market Snippet by Country
    • 2.1.5. Syphilis Immunoassay Diagnostic Market Snippet by Region
  • 2.2. Competitive Insights

3. Syphilis Immunoassay Diagnostic Key Market Trends

  • 3.1. Syphilis Immunoassay Diagnostic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Syphilis Immunoassay Diagnostic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Syphilis Immunoassay Diagnostic Market Opportunities
  • 3.4. Syphilis Immunoassay Diagnostic Market Future Trends

4. Syphilis Immunoassay Diagnostic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Syphilis Immunoassay Diagnostic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Syphilis Immunoassay Diagnostic Market Landscape

  • 6.1. Syphilis Immunoassay Diagnostic Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Syphilis Immunoassay Diagnostic Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Treponemal Tests
    • 7.1.3. Non-Treponemal Tests
    • 7.1.4. Point-of-Care (POC) Tests
    • 7.1.5. Automated Immunoassays

8. Syphilis Immunoassay Diagnostic Market - By Sample Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
    • 8.1.2. Blood
    • 8.1.3. Serum
    • 8.1.4. Plasma

9. Syphilis Immunoassay Diagnostic Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic Laboratories
    • 9.1.4. Blood Banks
    • 9.1.5. Community Clinics

10. Syphilis Immunoassay Diagnostic Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Syphilis Immunoassay Diagnostic Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Syphilis Immunoassay Diagnostic Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Beckman Coulter, Inc.
    • 11.2.3. Becton, Dickinson and Company
    • 11.2.4. bioMerieux S.A.
    • 11.2.5. Bio-Rad Laboratories, Inc.
    • 11.2.6. Cardinal Health, Inc.
    • 11.2.7. Cepheid Inc. (Danaher)
    • 11.2.8. Chembio Diagnostics, Inc.
    • 11.2.9. DiaSorin S.p.A.
    • 11.2.10. F. Hoffmann-La Roche AG
    • 11.2.11. Hologic, Inc.
    • 11.2.12. OraSure Technologies, Inc.
    • 11.2.13. Qiagen N.V.
    • 11.2.14. Siemens Healthineers AG
    • 11.2.15. Thermo Fisher Scientific Inc.
    • 11.2.16. Trinity Biotech plc
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us